NeuroPointDX Company Profile

10:46 EDT 19th March 2019 | BioPortfolio

NeuroPointDX is the diagnostics division of Stemina Biomarker Discovery. Stemina is a biotechnology company based in Madison, WI and Cambridge, MA that has developed a robust and reproducible proprietary platform for identifying changes in metabolism (“biomarkers”) utilizing highly sensitive analytical equipment and its proprietary platform technology. The Company’s diagnostics division, NeuroPointDX, identifies biomarkers of neurological disorders in cellular models of disease and human samples. These biomarkers provide greater insight into the pathways that are disrupted in patients with neurological disorders. This information can be translated into clinical diagnostics, individualized treatment recommendations, and new potential therapies.

News Articles [6 Associated News Articles listed on BioPortfolio]

NeuroPointDX test released for early autism diagnosis

NeuroPointDX has launched its NPDX AA test, which is intended to detect metabolic subtypes linked to autism spectrum disorder -More- 

NeuroPointDX Appoints Noted Neurodevelopmental Expert, Marvin Natowicz, M.D., Ph.D. to its Scientific Advisory Board

NeuroPointDX today announced the appointment of Marvin Natowicz, M.D., Ph.D., medical geneticist and clinical pathologist at the Cleveland Clinic and Professor of Pathology at the...

NeuroPointDX Names E. Robert Wassman, M.D. as Medical Director

Clinician and leader in development of personalized medicine approaches to autism spectrum disorder and other neurodevelopmental conditions NeuroPointDX, a division of ...

NeuroPointDX Announces Commercialization of First Objective Blood Test to Aid Earlier Diagnosis of Autism Spectrum Disorder

New test identifies metabolic subtypes in about 30% of children with autism spectrum disorder (ASD), based on findings from the largest clinical study of the metaboli...

NeuroPointDX to Present Precision Medicine Approaches to Diagnosing and Treating Autism at National TACA Autism Conference

Company Will Present New Data from the 1,100 Patient Clinical Study, the Children’s Autism Metabolome Project (CAMP) NeuroPointDX, a business unit of Stemi...

Earlier Autism Diagnosis Possible for Some Children Based on Metabolic Biomarkers in Blood, New Research Shows

New biomarkers detected in 1,100 subject study accurately identify specific subtypes of ASD related to abnormalities in metabolizing certain amino acids Metabolic signa...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [2 Associated Companies listed on BioPortfolio]


NeuroPointDX is the diagnostics division of Stemina Biomarker Discovery. Stemina is a biotechnology company based in Madison, WI and Cambridge, MA that has developed a robust and ...

Stemina Biomarker Discovery Inc.

Stemina Biomarker Discovery was founded in 2007 and is located in Madison, Wisconsin. Stemina is a biomarker discovery company focused on diagnosis and individualized treatment of...

More Information about "NeuroPointDX" on BioPortfolio

We have published hundreds of NeuroPointDX news stories on BioPortfolio along with dozens of NeuroPointDX Clinical Trials and PubMed Articles about NeuroPointDX for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NeuroPointDX Companies in our database. You can also find out about relevant NeuroPointDX Drugs and Medications on this site too.

Quick Search


Relevant Topic

Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Corporate Database Quicklinks

Searches Linking to this Company Record